期刊文献+

生脉饮研究现状及其制剂开发中的问题分析 被引量:29

Research on the present situation of Shengmaiyin and the development of Shengmai preparations
暂未订购
导出
摘要 生脉饮源于《医学启源》,为中医益心复脉之经方,乃中医危重急症的常用药。本文收集整理了近20年来有关生脉制剂的文献报道,对其物质基础、药理作用进行系统梳理,分析生脉制剂中不同剂型处方组成、配比差异及提取工艺对其功效的影响,以探究生脉饮及其成药制剂各关键环节的核心问题所在,为深化生脉饮基础研究,加快其"现代化"进程提供参考。 Shengmai Decoction, firstly recorded in "Medicine Origin", is a classical traditional Chinese medicine prescription having the effect of benefiting heart and restoring pulse, which is frequently used in clinical practice for critical illness. In this review, the literatures about Shengmai preparations in the last 20 years were collected and sorted out. The material basis and pharmacological effects of Shengmai preparations were systematically analyzed. And analysis were also conducted to explore the different prescription compositions, ratio of dosage forms and extraction processes on the effect of Shengmai preparations. Therefore, the core problems in the critical preparation processes of Shengmaiyin and its medicinal preparations were found out, and the paper provides references for further study of Shenmaiyin and the acceleration of its "modernization" process.
出处 《中药与临床》 2017年第2期69-73,共5页 Pharmacy and Clinics of Chinese Materia Medica
基金 国家自然科学基金项目(81373987) 国家自然科学基金项目(81403123)
关键词 生脉饮 研究现状 中药现代化 核心问题 Shengmaiyin research status modernization of traditional Chinese medicine core issues
  • 相关文献

参考文献35

二级参考文献381

共引文献2188

同被引文献442

引证文献29

二级引证文献173

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部